Profile data is unavailable for this security.
About the company
Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In addition to that, remimazolam, which is in Phase III clinical development, can be reversed with flumazenil to terminate sedation and anesthesia, if necessary. The product can be used for general anesthesia in Europe and procedural sedation in the United States. The Company operates sites in Aachen, Germany, Cambridge, the United Kingdom, and New Jersey, the United States.
- Revenue in EUR (TTM)--
- Net income in EUR--
- Incorporated2004
- Employees64.00
- LocationPaion AGHeussstrasse 25AACHEN 52078GermanyDEU
- Phone+49 24144530
- Fax+49 2 414453100
- Websitehttps://www.paion.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neovacs SA | 533.41k | -8.74m | 92.37k | 22.00 | -- | 0.0002 | -- | 0.1732 | -30,639.66 | -30,639.66 | 1.52 | 138.89 | 0.0099 | -- | 1.84 | 24,245.91 | -16.21 | -24.42 | -17.66 | -28.28 | 5.50 | -232.13 | -1,639.16 | -6,444.71 | -- | -- | 0.0131 | -- | 47,954.95 | -- | -146.40 | -- | 82.72 | -- |
| European Institute of Science AB | 58.51k | -235.03k | 117.97k | 2.00 | -- | 1.33 | -- | 2.02 | -4.23 | -4.23 | 1.05 | 1.93 | 0.2438 | 1.24 | 9.47 | 343,435.00 | -97.95 | -93.04 | -105.15 | -103.14 | 59.32 | 66.99 | -401.71 | -518.86 | 5.70 | -- | 0.00 | -- | 13.66 | 8.54 | 0.3974 | -- | -- | -- |
| Paion AG | -100.00bn | -100.00bn | 178.13k | 64.00 | -- | -- | -- | -- | -- | -- | -- | -0.4074 | -- | -- | -- | -- | -- | -24.86 | -- | -34.32 | -- | -- | -- | -52.40 | 0.5078 | -- | 1.17 | -- | 366.42 | 41.74 | 97.34 | -- | 129.37 | -- |
| Asarina Pharma AB (publ) | 0.00 | -1.09m | 253.61k | 2.00 | -- | 1.81 | -- | -- | -0.5666 | -0.5666 | 0.00 | 0.0728 | 0.00 | -- | -- | 0.00 | -111.87 | -61.25 | -157.85 | -71.89 | -- | -- | -- | -- | -- | -- | 0.3775 | -- | -- | -- | 3.43 | -- | -- | -- |
| Epigenomics AG | 448.00k | -16.29m | 465.98k | 18.00 | -- | 0.2378 | -- | 1.04 | -19.49 | -19.49 | 0.536 | 2.24 | 0.0361 | 2.73 | 3.34 | 13,176.47 | -131.18 | -65.64 | -167.31 | -83.85 | 76.56 | 89.26 | -3,636.16 | -548.19 | 1.93 | -- | 0.1572 | -- | -92.18 | -23.61 | -395.22 | -- | 44.06 | -- |
| Theravet SA | -100.00bn | -100.00bn | 672.67k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 2cureX AB | 13.20k | -2.77m | 824.67k | 14.00 | -- | 0.8016 | -- | 62.46 | -1.85 | -1.85 | 0.0088 | 0.6861 | 0.0049 | -- | 0.1147 | 11,071.43 | -101.72 | -38.93 | -117.90 | -44.42 | -7,782.58 | -22,717.96 | -20,979.36 | -39,378.78 | -- | -46.38 | 0.00 | -- | 72.22 | -- | -9.23 | -- | -57.30 | -- |
Data as of Jul 26 2024. Currency figures normalised to Paion AG's reporting currency: Euro EUR
1.26%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FPS Verm�gensverwaltung GmbHas of 31 Dec 2023 | 85.93k | 1.21% |
| Gutmann Finanz Strategien AGas of 31 Mar 2024 | 4.20k | 0.06% |
| Baring Asset Management Ltd.as of 31 Oct 2023 | 0.00 | 0.00% |
| Hauck & Aufh�user Fund Services SAas of 31 Jan 2024 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 28 Jun 2024Source: FactSet Research Systems Inc.
